ArticleJournal of thoracic disease2025
Lobectomy
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comparative outcomes of lobectomy and combined segmentectomy in left upper-lobe lung cancer: a propensity score-matched analysis.Journal of thoracic disease · 2026Article
- Oncological and Surgical Outcomes of Left Trisegmentectomy or Lingulectomy Versus Upper Lobectomy for Early-Stage Non-Small Cell Lung Cancer: A Multicentre Study.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lobectomy has been established as the standard treatment for resectable non-small cell lung cancer (NSCLC) since the publication of a randomized prospective clinical trial conducted by the Lung Cancer Study Group (LCSG) in the 1990s. However, this study possesses certain drawbacks from a contemporary standpoint. Over the past decades, further studies have been conducted to comprehensively outline appropriate surgical procedures for NSCLC. Segmentectomy is considered a potential alternative for predominant ground-glass opacities (GGOs) or tumors smaller than 2 cm. However, there is limited research regarding their relative benefits. We compared oncological outcomes of patients undergoing left upper lobectomy and a "multi-segmentectomy" [trisegmentectomy (S Methods: A retrospective study was performed in the Department of Thoracic Surgery, Zhongshan Hospital of Fudan University, that included patients who underwent lobectomy and bisegmentectomy for NSCLC in the left upper lobe from January 2009 to December 2016. Oncological outcomes, including OS and DFS, were compared between patients who underwent lobectomy and those who underwent bisegmentectomy. Subgroup analyses were completed based on the type of operation and tumor size. Results: A total of 997 patients were included, with 888 undergoing left upper lobectomy, 33 undergoing lingulectomy, and 76 undergoing inherent segmentectomy. After a retrospective comparative cohort study, no significant differences were observed in OS (P=0.49) or DFS (P=0.62) between the lobectomy and bisegmentectomy groups. Subgroup analyses were performed for each type of bisegmentectomy and different tumor sizes. Despite a noted inferior OS in the lingulectomy group (P=0.049), no significant difference in OS or DFS was identified in the other subgroup comparisons (P>0.05). Conclusions: Left upper bisegmentectomy demonstrated comparable oncological outcomes to those of left upper lobectomy, even in cases of larger tumor size (≥2 cm). However, the lingulectomy group exhibited a concerning inferiority in OS, necessitating further evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.